Position in ROIV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,592
+$346 QoQ
Shares Held
45
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#460
of 494 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SouthState Bank Corp holds $75,082 across 25 Biotechnology names. ROIV ranks #11 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45 | $22,352 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
21 | $13,094 | |
| 3 | CBUS |
Cibus, Inc.
|
3,511 | $4,810 | |
| 4 | INCY |
Incyte Corp
|
41 | $4,647 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
19 | $4,577 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
11 | $3,311 | |
| 7 | MRNA |
Moderna, Inc.
|
39 | $2,731 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
50 | $2,727 |
All Filings in ROIV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,592 | 45 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $1,246 | 45 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,475 | 68 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,996 | 132 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $507 | 45 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $474 | 47 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||